January 2020

Modeling Challenges of Ebola Virus -Host Dynamics during Infection and Treatment

Chertow D.S., et al.

VIRUSES

April 2020

Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg

Shekhtman L, et al.

SCIENTIFIC REPORTS

​

​

​

​

July 2020

Understanding hepatitis B virus dynamics and the antiviral effect of interferon-a treatment in humanized chimeric mice

Canini L., et al.

BIORXIV

September 2020

Letter to the Editor: Examining HBV RNA kinetics during NA treatment - are NA multifunctional antiviral agents?

Dahari H., et al.

HEPATOLOGY

April 2020

Sustained Virological Response Following an 11 Day Course of Direct Acting Antiviral Therapy for Hepatitis C Infection

Yardeni D, et al.

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES

May 2020

Evaluation of short-course direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: A single-centre, open-label study

Feld J.J., et al.

THE LANCET GASTROENTEROLOGY & HEPATOLOGY

July 2020

HCVMultiscaleFit: A Simulator for Parameter Estimation in Multiscale Models of Hepatitis C Virus Dynamics

Churkin A., et al.

AIP CONFERENCE PROCEEDINGS

October 2020

Re-treatment with direct-acting antivirals policy is needed to eliminate Hepatitis C among persons who inject drugs

Tatara E., et al.

ARXIV

August 2020

Efficient Methods for Parameter Estimation of Ordinary and Partial Differential Equation Models of Viral Hepatitis Kinetics

Churkin A., et al.

MATHEMATICS SPECIAL ISSUE MATHEMATICAL MODELING IN BIOMEDICINE

April 2020

Modeling-based response-guided therapy for chronic hepatitis C under glecaprevir/pibrentasvir may identify patients for ultra-short treatment duration

Dasgupta S, et al.

JOURNAL OF INFECTIOUS DISEASES

June 2020

Modeling based response guided therapy in subjects with recent hepatitis C infection

Gorstein E., et al.

ANTIVIRAL RESEARCH

July 2020

Understanding the antiviral effects of RNAi-based therapy on chronic hepatitis B infection

Kadelka S., et al.

BIORXIV

October 2020

Efficacy and Safety of Modeling-Based Response Guided Therapy with Direct Acting Anti-Viral Agents for Treatment Optimization in Chronic Hepatitis C Infection- A Pilot Study

Etzion O., et al.

SCIENTIFIC REPORTS

August 2020

Modeling hepatitis C virus kinetics during liver transplantation highlights the role of the liver in virus clearance

Shekhtman L., et al.

MEDRXIV

January 2020

Modeling Challenges of Ebola Virus -Host Dynamics during Infection and Treatment

Chertow D.S., et al.

VIRUSES

April 2020

Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg

Shekhtman L, et al.

SCIENTIFIC REPORTS

​

​

​

​

July 2020

Understanding hepatitis B virus dynamics and the antiviral effect of interferon-a treatment in humanized chimeric mice

Canini L., et al.

BIORXIV

September 2020

Letter to the Editor: Examining HBV RNA kinetics during NA treatment - are NA multifunctional antiviral agents?

Dahari H., et al.

HEPATOLOGY

April 2020

Sustained Virological Response Following an 11 Day Course of Direct Acting Antiviral Therapy for Hepatitis C Infection

Yardeni D, et al.

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES

May 2020

Evaluation of short-course direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: A single-centre, open-label study

Feld J.J., et al.

THE LANCET GASTROENTEROLOGY & HEPATOLOGY

July 2020

HCVMultiscaleFit: A Simulator for Parameter Estimation in Multiscale Models of Hepatitis C Virus Dynamics

Churkin A., et al.

AIP CONFERENCE PROCEEDINGS

October 2020

Re-treatment with direct-acting antivirals policy is needed to eliminate Hepatitis C among persons who inject drugs

Tatara E., et al.

ARXIV

August 2020

Efficient Methods for Parameter Estimation of Ordinary and Partial Differential Equation Models of Viral Hepatitis Kinetics

Churkin A., et al.

MATHEMATICS SPECIAL ISSUE MATHEMATICAL MODELING IN BIOMEDICINE

April 2020

Modeling-based response-guided therapy for chronic hepatitis C under glecaprevir/pibrentasvir may identify patients for ultra-short treatment duration

Dasgupta S, et al.

JOURNAL OF INFECTIOUS DISEASES

June 2020

Modeling based response guided therapy in subjects with recent hepatitis C infection

Gorstein E., et al.

ANTIVIRAL RESEARCH

July 2020

Understanding the antiviral effects of RNAi-based therapy on chronic hepatitis B infection

Kadelka S., et al.

BIORXIV

October 2020

Efficacy and Safety of Modeling-Based Response Guided Therapy with Direct Acting Anti-Viral Agents for Treatment Optimization in Chronic Hepatitis C Infection- A Pilot Study

Etzion O., et al.

SCIENTIFIC REPORTS

August 2020

Modeling hepatitis C virus kinetics during liver transplantation highlights the role of the liver in virus clearance

Shekhtman L., et al.

MEDRXIV